R&D Roadmapping

Product Owner-level support to organizations that recognize this as a Horizon 2 activity.

What is Horizon 2?

The Three Horizons Framework – A quick recap:

  • Horizon 1 (H1): Core business – focuses on maintaining and defending existing business models and revenue streams.
  • Horizon 2 (H2): Emerging opportunities – businesses that are starting to show traction but are not yet fully scaled.
  • Horizon 3 (H3): Future bets – often radical innovations, explorations, or early-stage ideas that may not yet show economic viability.

Why Horizon 2?

We believe that once pharma structurally supports these areas as Horizon 2 initiatives, it will scale them faster than any startup can — by virtue of having direct access to patients, payers, and providers.

We’re not making a prediction. We’re making a distinction — between where we add value and where we don’t.

If your organization is building H2 governance, we can help — as strategy partners and Product Owner-level support. We also support startups that see Pharma collaboration as their path to scale. We are here to help make that future actionable.

We’re not best suited to support companies at H1 who are already competing to consolidate leadership in a saturated space.

See related topic